The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients
Authors:
- Nancy L. SheehanNSNancy L. Sheehan
- Rolf P. G. van HeeswijkRHRolf P. G. van Heeswijk
- Brian C. FosterBFBrian C. Foster
- Humayoun AkhtarHAHumayoun Akhtar
- Neera SinghalNSNeera Singhal
- Isabelle SeguinISIsabelle Seguin
- Lina DelBalsoLDLina DelBalso
- Marc BourbeauMBMarc Bourbeau
- Bobby M. ChauhanBCBobby M. Chauhan
- Mohammed-Rachid BoulasselMBMohammed-Rachid Boulassel
- David M. BurgerDBDavid M. Burger
- Richard G. LalondeRLRichard G. Lalonde
Open Access
Abstract
β-Carotene supplements are often taken by individuals living with HIV-1. Contradictory results from in vitro studies suggest that β-carotene may inhibit or induce cytochrome P450 enzymes and transporters. The study objective was to investigate the effect of β-carotene on the steady-state pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1 infected individuals. Twelve hour nelfinavir pharmacokinetic analysis was conducted at baseline and after 28 days of β-carotene supplementation (25,000 IU twice daily). Nelfinavir and M8 concentrations were measured with validated assays. Non-compartmental methods were used to calculate the pharmacokinetic parameters. Geometric mean ratios comparing day 28 to day 1 area under the plasma concentration-time curve (AUC0–12 h), maximum (Cmax) and minimum (Cmin) concentrations of nelfinavir and M8 are presented with 90% confidence intervals. Eleven subjects completed the study and were included in the analysis. There were no significant differences in nelfinavir AUC0–12 h and Cmin (−10%, +4%) after β-carotene supplementation. The M8 Cmin was increased by 31% while the M8 AUC0–12 h and Cmax were unchanged. During the 28 day period, mean CD4+ % and CD4+:CD8+ ratio increased significantly (p < 0.01). β-carotene supplementation increased serum carotene levels but did not cause any clinically significant difference in the nelfinavir and M8 exposure.Keywords
This publication has 37 references indexed in Scilit:
- Editorial Board: Mol. Nutr. Food Res.Molecular Nutrition & Food Research, 2011
- A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndromeEuropean Journal of Clinical Nutrition, 2006
- Clinical Pharmacokinetics of Nelfinavir and Its Metabolite M8 in Human Immunodeficiency Virus (HIV)-Positive and HIV-Hepatitis C Virus-Coinfected SubjectsAntimicrobial Agents and Chemotherapy, 2005
- Absorption and retinol equivalence of β-carotene in humans is influenced by dietary vitamin A intakeJournal of Lipid Research, 2003
- Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus‐infected patients with chronic liver diseaseBritish Journal of Clinical Pharmacology, 2000
- S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among EthiopiansPharmacogenetics, 1996
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.Gut, 1995
- Vitamin E enhances the lymphatic transport of β-carotene and its conversion to vitamin A in the ferretGastroenterology, 1995
- Oral beta-carotene can increase the number of OKT4+ cells in human bloodImmunology Letters, 1985